quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:13:02·36d
SECFiling
argenx SE logo

SEC Form 20-F filed by argenx SE

ARGX· argenx SE
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • ARGX
    argenx SE
    Health Care

Recent analyst ratings

  • Mar 10UpdateDeutsche Bank-
  • Dec 18UpdateRobert W. Baird$858.00
  • Nov 24UpdateWolfe Research-
  • Sep 15UpdateTruist$918.00
  • Sep 11UpdateDeutsche Bank-
  • Aug 25UpdateRBC Capital Mkts$850.00

Related

  • SEC4d
    SEC Form 6-K filed by argenx SE
  • PR6d
    argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP
  • SEC34d
    SEC Form 6-K filed by argenx SE
  • PR34d
    argenx announces Annual General Meeting of Shareholders on May 6, 2026
  • SEC36d
    SEC Form 6-K filed by argenx SE
  • ANALYST44d
    argenx upgraded by Deutsche Bank
  • SEC48d
    SEC Form 6-K filed by argenx SE
  • PR49d
    argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022